Novozymes A/S and Chr Hansen Holding A/S to Discuss Agreement to Combine Through a Statutory Merger Call Transcript
/-
Good morning, everyone, and thank you for joining us on this very exciting day for both Novozymes and Chr. Hansen. My name is Tobias Björklund, and I'm the Head of Investor Relations here at Novozymes, as mentioned. Please turn to Slide #2, and highlighting the disclaimer for this presentation. We move to Slide #3.
Joining us at today's call are Ester Baiget, President and CEO of Novozymes; Lars Green, EVP and CFO of Novozymes; Mauricio Graber, President and CEO of Chr. Hansen; and Anders Mohr Christensen, Head of IR and Strategy from Chr. Hansen. Today's call will focus on the stock exchange announcement from this morning that Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner. Links to the stock exchange announcement and relevant additional materials, such as this presentation, can be found through our respective company websites, www.power-with-biology.com or
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
